<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Xtant Medical Holdings, Inc. — News on 6ix</title>
<link>https://6ix.com/company/xtant-medical-holdings-inc</link>
<description>Latest news and press releases for Xtant Medical Holdings, Inc. on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Thu, 09 Apr 2026 12:00:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/xtant-medical-holdings-inc" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo69d7976224982d98966dda0a.webp</url>
<title>Xtant Medical Holdings, Inc.</title>
<link>https://6ix.com/company/xtant-medical-holdings-inc</link>
</image>
<item>
<title>Xtant Medical and Montana Governor's Office of Community Service Announce Support for "Threshold of Life" Memorial</title>
<link>https://6ix.com/company/xtant-medical-holdings-inc/news/xtant-medical-and-montana-governors-office-of-community-service-announce-support-for-threshold-of-life-memorial</link>
<guid isPermaLink="true">https://6ix.com/company/xtant-medical-holdings-inc/news/xtant-medical-and-montana-governors-office-of-community-service-announce-support-for-threshold-of-life-memorial</guid>
<pubDate>Thu, 09 Apr 2026 12:00:00 GMT</pubDate>
<description>Xtant Medical Holdings, Inc. (NYSE American: XTNT), in partnership with the Montana Governor's Office of Community Service (GOCS), today announced support for the Threshold of Life Memorial, a statewide initiative honoring organ, eye, and tissue donors and the lives they have impacted.</description>
</item>
<item>
<title>Xtant Medical Reports Fourth Quarter and Full-Year 2025 Financial Results</title>
<link>https://6ix.com/company/xtant-medical-holdings-inc/news/xtant-medical-reports-fourth-quarter-and-full-year-2025-financial-results</link>
<guid isPermaLink="true">https://6ix.com/company/xtant-medical-holdings-inc/news/xtant-medical-reports-fourth-quarter-and-full-year-2025-financial-results</guid>
<pubDate>Tue, 31 Mar 2026 11:00:00 GMT</pubDate>
<description>Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for spinal and other orthopedic conditions, today reported financial and operating results for the fourth quarter and full-year ended December 31, 2025.</description>
</item>
<item>
<title>Xtant Medical to Announce Fourth Quarter and Full Year 2025 Financial Results on March 31, 2026</title>
<link>https://6ix.com/company/xtant-medical-holdings-inc/news/xtant-medical-to-announce-fourth-quarter-and-full-year-2025-financial-results-on-march-31-2026</link>
<guid isPermaLink="true">https://6ix.com/company/xtant-medical-holdings-inc/news/xtant-medical-to-announce-fourth-quarter-and-full-year-2025-financial-results-on-march-31-2026</guid>
<pubDate>Wed, 25 Mar 2026 12:00:00 GMT</pubDate>
<description>Xtant Medical Holdings, Inc. (NYSE American: XTNT), a medical technology company focused on surgical solutions for spinal and other orthopedic conditions, today announced that it will release its financial results for the fourth quarter and full year ended December 31, 2025, before the start of trading on Tuesday, March 31, 2026. Sean Browne, President and Chief Executive Officer, and Scott Neils, Chief Financial Officer, will host a conference call at 8:30 AM ET on that day.</description>
</item>
<item>
<title>Xtant Medical Finalizes Companion Spine Transactions</title>
<link>https://6ix.com/company/xtant-medical-holdings-inc/news/xtant-medical-finalizes-companion-spine-transactions</link>
<guid isPermaLink="true">https://6ix.com/company/xtant-medical-holdings-inc/news/xtant-medical-finalizes-companion-spine-transactions</guid>
<pubDate>Mon, 02 Mar 2026 13:00:00 GMT</pubDate>
<description>Xtant Medical Holdings, Inc. (NYSE American: XTNT), a medical technology company focused on surgical solutions for spinal and other orthopedic conditions, today announced that it has received $10.7 million from Companion Spine related to Companion Spine's purchase of Xtant's Coflex® assets and Paradigm OUS businesses in December 2025, bringing the total aggregate purchase price for the two divestitures to $21.4 million. With this payment, the transactions have now been finalized.</description>
</item>
<item>
<title>Xtant Medical to Participate in the Canaccord Genuity 2026 Musculoskeletal Conference</title>
<link>https://6ix.com/company/xtant-medical-holdings-inc/news/xtant-medical-to-participate-in-the-canaccord-genuity-2026-musculoskeletal-conference</link>
<guid isPermaLink="true">https://6ix.com/company/xtant-medical-holdings-inc/news/xtant-medical-to-participate-in-the-canaccord-genuity-2026-musculoskeletal-conference</guid>
<pubDate>Wed, 25 Feb 2026 13:00:00 GMT</pubDate>
<description>Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal, orthopedic, and wound care disorders, today announced that Sean Browne, CEO, Scott Neils, CFO, and Mark Schallenberger, COO, will be participating in the Canaccord Genuity 2026 Musculoskeletal Conference, which is being held March 2, 2026, in New Orleans and virtually.</description>
</item>
<item>
<title>Xtant Medical Announces Commercial Launch of its Next-Generation nanOss Strata™ Synthetic Bone Graft</title>
<link>https://6ix.com/company/xtant-medical-holdings-inc/news/xtant-medical-announces-commercial-launch-of-its-next-generation-nanoss-stratatm-synthetic-bone-graft</link>
<guid isPermaLink="true">https://6ix.com/company/xtant-medical-holdings-inc/news/xtant-medical-announces-commercial-launch-of-its-next-generation-nanoss-stratatm-synthetic-bone-graft</guid>
<pubDate>Thu, 11 Dec 2025 13:00:00 GMT</pubDate>
<description>Xtant Medical Holdings, Inc. (NYSE American: XTNT), a medical technology company focused on surgical solutions for spinal and other orthopedic conditions, today announced the commercial launch of its next-generation innovative synthetic bone graft in the nanOss line, Strata™.</description>
</item>
<item>
<title>Xtant Medical Completes Sale of its Coflex® Assets and Paradigm OUS Businesses to Companion Spine</title>
<link>https://6ix.com/company/xtant-medical-holdings-inc/news/xtant-medical-completes-sale-of-its-coflexr-assets-and-paradigm-ous-businesses-to-companion-spine</link>
<guid isPermaLink="true">https://6ix.com/company/xtant-medical-holdings-inc/news/xtant-medical-completes-sale-of-its-coflexr-assets-and-paradigm-ous-businesses-to-companion-spine</guid>
<pubDate>Mon, 01 Dec 2025 21:05:00 GMT</pubDate>
<description>Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for spinal and other orthopedic conditions, today announced that the company has completed its previously announced sale of certain non-core Coflex® spinal implant assets and all OUS entities of Paradigm Spine GmbH to Companion Spine, LLC, and its affiliates.</description>
</item>
<item>
<title>Xtant Medical Reports Third Quarter 2025 Financial Results</title>
<link>https://6ix.com/company/xtant-medical-holdings-inc/news/xtant-medical-reports-third-quarter-2025-financial-results</link>
<guid isPermaLink="true">https://6ix.com/company/xtant-medical-holdings-inc/news/xtant-medical-reports-third-quarter-2025-financial-results</guid>
<pubDate>Mon, 10 Nov 2025 21:28:00 GMT</pubDate>
<description>Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for spinal and other orthopedic conditions, today reported financial and operating results for the third quarter ended September 30, 2025.</description>
</item>
<item>
<title>Xtant Medical Announces Commercial Launch of CollagenX™</title>
<link>https://6ix.com/company/xtant-medical-holdings-inc/news/xtant-medical-announces-commercial-launch-of-collagenxtm</link>
<guid isPermaLink="true">https://6ix.com/company/xtant-medical-holdings-inc/news/xtant-medical-announces-commercial-launch-of-collagenxtm</guid>
<pubDate>Wed, 05 Nov 2025 13:00:00 GMT</pubDate>
<description>Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal, orthopedic, and wound care disorders, today announced the commercial launch of CollagenX™, its bovine collagen particulate product for surgical wound closure designed to promote healing, prevent dehiscence, and help mitigate concerns related to surgical site infections.</description>
</item>
<item>
<title>Xtant Medical to Announce Third Quarter 2025 Financial Results on November 11, 2025</title>
<link>https://6ix.com/company/xtant-medical-holdings-inc/news/xtant-medical-to-announce-third-quarter-2025-financial-results-on-november-11-2025</link>
<guid isPermaLink="true">https://6ix.com/company/xtant-medical-holdings-inc/news/xtant-medical-to-announce-third-quarter-2025-financial-results-on-november-11-2025</guid>
<pubDate>Tue, 04 Nov 2025 13:00:00 GMT</pubDate>
<description>Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal, orthopedic, and woundcare disorders, today announced that it will release its financial results for the third quarter ended September 30, 2025, before the start of trading on Tuesday, November 11, 2025.</description>
</item>
<item>
<title>Xtant Medical to Participate in the H.C. Wainwright 27th Annual Global Investment Conference</title>
<link>https://6ix.com/company/xtant-medical-holdings-inc/news/xtant-medical-to-participate-in-the-hc-wainwright-27th-annual-global-investment-conference</link>
<guid isPermaLink="true">https://6ix.com/company/xtant-medical-holdings-inc/news/xtant-medical-to-participate-in-the-hc-wainwright-27th-annual-global-investment-conference</guid>
<pubDate>Thu, 04 Sep 2025 12:57:00 GMT</pubDate>
<description>Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal, orthopedic, and woundcare disorders, today announced that Sean Browne, CEO, and Scott Neils, CFO, will be participating in the H.C. Wainwright 27th Annual Global Investment Conference, which is being held September 8-10, 2025, in New York and virtually.</description>
</item>
<item>
<title>Xtant Medical Reports Second Quarter 2025 Financial Results</title>
<link>https://6ix.com/company/xtant-medical-holdings-inc/news/xtant-medical-reports-second-quarter-2025-financial-results</link>
<guid isPermaLink="true">https://6ix.com/company/xtant-medical-holdings-inc/news/xtant-medical-reports-second-quarter-2025-financial-results</guid>
<pubDate>Tue, 12 Aug 2025 11:00:00 GMT</pubDate>
<description>Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal, orthopedic, and woundcare disorders, today reported financial and operating results for the second quarter ended June 30, 2025.</description>
</item>
<item>
<title>Xtant Medical to Attend the CG 45th Annual Growth Conference</title>
<link>https://6ix.com/company/xtant-medical-holdings-inc/news/xtant-medical-to-attend-the-cg-45th-annual-growth-conference</link>
<guid isPermaLink="true">https://6ix.com/company/xtant-medical-holdings-inc/news/xtant-medical-to-attend-the-cg-45th-annual-growth-conference</guid>
<pubDate>Wed, 06 Aug 2025 20:01:00 GMT</pubDate>
<description>Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal, orthopedic, and woundcare disorders, today announced that Sean Browne, CEO and Scott Neils, CFO will be attending the following upcoming conference:</description>
</item>
<item>
<title>Xtant Medical to Announce Second Quarter 2025 Financial Results on August 12, 2025</title>
<link>https://6ix.com/company/xtant-medical-holdings-inc/news/xtant-medical-to-announce-second-quarter-2025-financial-results-on-august-12-2025</link>
<guid isPermaLink="true">https://6ix.com/company/xtant-medical-holdings-inc/news/xtant-medical-to-announce-second-quarter-2025-financial-results-on-august-12-2025</guid>
<pubDate>Tue, 05 Aug 2025 12:00:00 GMT</pubDate>
<description>Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal, orthopedic, and woundcare disorders, today announced that it will release its financial results for the second quarter ended June 30, 2025, before the start of trading on Tuesday, August 12, 2025.</description>
</item>
<item>
<title>Xtant Medical Partners With B2i Digital to Educate Investors on Its Orthobiologics Innovation and Market Opportunity</title>
<link>https://6ix.com/company/xtant-medical-holdings-inc/news/xtant-medical-partners-with-b2i-digital-to-educate-investors-on-its-orthobiologics-innovation-and-market-opportunity</link>
<guid isPermaLink="true">https://6ix.com/company/xtant-medical-holdings-inc/news/xtant-medical-partners-with-b2i-digital-to-educate-investors-on-its-orthobiologics-innovation-and-market-opportunity</guid>
<pubDate>Mon, 28 Jul 2025 22:11:32 GMT</pubDate>
<description>The Partnership Will Deliver Centralized, Investor-focused Content to Help Retail and Institutional Audiences Gain Insight Into Xtant's Orthobiologics Platform and Long-term Value Proposition NEW YORK, NY - July 28, 2025 (NEWMEDIAWIRE) - B2i Digital ...</description>
</item>
<item>
<title>Xtant Medical Announces Definitive Agreements for the Sale of its Coflex® and CoFix® Spinal Implants and All OUS Businesses to Companion Spine</title>
<link>https://6ix.com/company/xtant-medical-holdings-inc/news/xtant-medical-announces-definitive-agreements-for-the-sale-of-its-coflexr-and-cofixr-spinal-implants-and-all-ous-businesses-to-companion-spine</link>
<guid isPermaLink="true">https://6ix.com/company/xtant-medical-holdings-inc/news/xtant-medical-announces-definitive-agreements-for-the-sale-of-its-coflexr-and-cofixr-spinal-implants-and-all-ous-businesses-to-companion-spine</guid>
<pubDate>Tue, 08 Jul 2025 12:00:00 GMT</pubDate>
<description>Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal, orthopedic, and woundcare disorders, today announced that the company has entered into agreements to sell certain Coflex® and CoFix® interlaminar stabilization implant assets and all OUS entities of Paradigm Spine GmbH, to Companion Spine, LLC, a French-American company fully dedicated to posterior dynamic spine stabilization and motion preservation s</description>
</item>
<item>
<title>Xtant Medical Announces the Launch of OsteoFactor Pro™</title>
<link>https://6ix.com/company/xtant-medical-holdings-inc/news/xtant-medical-announces-the-launch-of-osteofactor-protm</link>
<guid isPermaLink="true">https://6ix.com/company/xtant-medical-holdings-inc/news/xtant-medical-announces-the-launch-of-osteofactor-protm</guid>
<pubDate>Wed, 28 May 2025 12:00:00 GMT</pubDate>
<description>Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal, orthopedic and wound care disorders, today announced the commercial launch of OsteoFactor Pro™, a naturally occurring cocktail of allogeneic growth factors engineered to improve bone healing and support surgical success across orthopedic and spine procedures.</description>
</item>
<item>
<title>Xtant Medical Reports First Quarter 2025 Financial Results</title>
<link>https://6ix.com/company/xtant-medical-holdings-inc/news/xtant-medical-reports-first-quarter-2025-financial-results</link>
<guid isPermaLink="true">https://6ix.com/company/xtant-medical-holdings-inc/news/xtant-medical-reports-first-quarter-2025-financial-results</guid>
<pubDate>Mon, 12 May 2025 20:05:00 GMT</pubDate>
<description>Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal, orthopedic, and wound care disorders, today reported financial and operating results for the first quarter ended March 31, 2025.</description>
</item>
<item>
<title>Xtant Medical to Issue First Quarter 2025 Financial Results on May 12, 2025</title>
<link>https://6ix.com/company/xtant-medical-holdings-inc/news/xtant-medical-to-issue-first-quarter-2025-financial-results-on-may-12-2025</link>
<guid isPermaLink="true">https://6ix.com/company/xtant-medical-holdings-inc/news/xtant-medical-to-issue-first-quarter-2025-financial-results-on-may-12-2025</guid>
<pubDate>Tue, 06 May 2025 12:00:00 GMT</pubDate>
<description>Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal, orthopedic and woundcare disorders, today announced that it will release its financial results for the first quarter ended March 31, 2025, after the close of the financial markets on Monday, May 12, 2025.</description>
</item>
<item>
<title>Xtant Medical Launches Trivium™ Advanced Bone Graft for Superior Performance</title>
<link>https://6ix.com/company/xtant-medical-holdings-inc/news/xtant-medical-launches-triviumtm-advanced-bone-graft-for-superior-performance</link>
<guid isPermaLink="true">https://6ix.com/company/xtant-medical-holdings-inc/news/xtant-medical-launches-triviumtm-advanced-bone-graft-for-superior-performance</guid>
<pubDate>Wed, 23 Apr 2025 12:00:00 GMT</pubDate>
<description>Xtant Medical Holdings, Inc.(NYSE American:XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal, orthopedic and woundcare disorders, is proud to announce the launch of Trivium™, a premium, next-generation demineralized bone matrix (DBM) allograft designed to elevate the standard of care in bone grafting procedures. Engineered with advanced PureLoc™ Fiber Technology, Trivium combines three synergistic elements intended to deliver exceptional perform</description>
</item>
</channel>
</rss>